Alto Neuroscience, Inc. (ANRO) Tops Q1 EPS by 1c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q1 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• Zhipu AI prices HK offering at HK$1,588/share - Reuters
• JPMorgan Upgrades Wolters Kluwer NV (WKL:NA) (WTKWY) to Overweight
• Voya Financial estimates Q2 alternative investment pre-tax loss of $9M-$19M